Clinical trial
A Study in Subjects With Retinal Detachment
NCT00210067 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00210067 |
|---|---|
| Title | A Study in Subjects With Retinal Detachment |
| Official title | A Double-Masked, Randomized, Dose-Ranging Study of a Single Intravitreal (IVT) Injection of INS37217 Intravitreal Injection in Subjects With Retinal Detachment |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Retinal Detachment |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) Intravitreal Injection |
| Enrollment | 14 |
| Start date | May 1, 2001 |
| Primary completion | Jun 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 9, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: